Expertise in
2
conditions

Dr. Robert A. Riesenberg

Psychiatry
Legacy Medical Center Of Atlanta Inc
501 Fairburn Rd SW, 
Atlanta, GA 
Expertise in
2
conditions
Legacy Medical Center Of Atlanta Inc
501 Fairburn Rd SW, 
Atlanta, GA 

Overview

Robert Riesenberg is a Psychiatrist practicing medicine in Atlanta, Georgia.

Dr. Riesenberg is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Postpartum Depression, Major Depression, Bipolar Disorder (BPD), and Dementia.

He is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 17 clinical trials.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in GA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Legacy Medical Center of Atlanta Inc
501 Fairburn Rd SW, Atlanta, GA 30331

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Drug
Study Phase: Phase 3
XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD)
XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD)
Enrollment Status: Completed
Publish Date: February 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
Enrollment Status: Terminated
Publish Date: May 09, 2024
Intervention Type: Drug
Study Drug: NaBen®
Study Phase: Phase 2/Phase 3
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
Enrollment Status: Withdrawn
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Drug
Study Drug: Tilavonemab
Study Phase: Phase 2
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

20 Total Publications

Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
Journal: The Journal of clinical psychiatry
Published: August 16, 2023
Similar Doctors
Expertise in
2
conditions
Expertise in
2
conditions
Referral may be required

Emory Brain Health Center

12 Executive Park Drive Northeast, 
Atlanta, GA 
 (14.7 miles away)
404-778-5526
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Boadie Dunlop is a Psychiatrist practicing medicine in Atlanta, Georgia. Dr. Dunlop is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Major Depression, Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder (GAD), and Bipolar Disorder (BPD). Dr. Dunlop is board certified in American Board Of Psychiatry And Neurology, 2002.

Expertise in
2
conditions
Expertise in
2
conditions
Referral may be required

Department Of Veterans Affairs

1670 Clairmont Rd, 
Decatur, GA 
 (14.1 miles away)
404-321-6111
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

James Bremner is a Psychiatrist practicing medicine in Decatur, Georgia. Dr. Bremner is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Post-Traumatic Stress Disorder (PTSD), Opioid Use Disorder, Major Depression, and Bipolar Disorder (BPD). Dr. Bremner is currently accepting new patients.

Expertise in
1
conditions
Expertise in
1
conditions
Referral may be required
Before you request

Outpatient Behavioral Health LLC

5755 N Point Pkwy Ste 256, 
Alpharetta, GA 
 (28.5 miles away)
770-817-9200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Angelo Sambunaris is a Psychiatrist practicing medicine in Alpharetta, Georgia. Dr. Sambunaris is highly rated in 1 condition, according to our data. His clinical expertise encompasses Major Depression. Dr. Sambunaris is currently accepting new patients.

Frequently Asked Questions about Dr. Robert A. Riesenberg

How do I make an appointment with Dr. Robert A. Riesenberg?

You can book an appointment with Dr. Robert A. Riesenberg by calling their office at 404-881-5800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert A. Riesenberg a top-rated expert for Postpartum Depression?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert A. Riesenberg is classified as an Elite expert for Postpartum Depression, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert A. Riesenberg specialize in?

While Dr. Robert A. Riesenberg is a Psychiatry, they have specific expertise in Postpartum Depression, Major Depression, and Bipolar Disorder (BPD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Robert A. Riesenberg participate in research or clinical trials?

Yes. Dr. Robert A. Riesenberg has published 20 articles and abstracts on conditions like Postpartum Depression. You can view a list of Dr. Robert A. Riesenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Riesenberg's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile